Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4)
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4)
Authors
Keywords
-
Journal
MedChemComm
Volume 2, Issue 6, Pages 455
Publisher
Royal Society of Chemistry (RSC)
Online
2011-03-02
DOI
10.1039/c0md00238k
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain
- (2014) Grzegorz Popowicz et al. CELL CYCLE
- Mitochondrial MDM4 (MDMX): An unpredicted role in the p53-mediated intrinsic apoptotic pathway
- (2011) Francesca Mancini et al. CELL CYCLE
- A Left-Handed Solution to Peptide Inhibition of the p53-MDM2 Interaction
- (2010) Min Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system
- (2010) Shreya Datta et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pharmacological Rescue of p53 in Cancer Therapy: Widening the Sensitive Tumor Spectrum by Targeting MDMX
- (2010) Jean-Christophe Marine CANCER CELL
- A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
- (2010) Federico Bernal et al. CANCER CELL
- Spontaneous Tumorigenesis in Mice Overexpressing the p53-Negative Regulator Mdm4
- (2010) S. Xiong et al. CANCER RESEARCH
- High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx
- (2010) Anna Czarna et al. CELL CYCLE
- Differential binding of p53 and nutlin to MDM2 and MDMX: Computational studies
- (2010) Thomas Leonard Joseph et al. CELL CYCLE
- Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery
- (2010) Grzegorz M. Popowicz et al. CELL CYCLE
- MDM4 binds ligands via a mechanism in which disordered regions become structured
- (2010) Maria C. Sanchez et al. FEBS LETTERS
- Puzzling over MDM4–p53 network
- (2010) F. Mancini et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Turning the RING Domain Protein MdmX into an Active Ubiquitin-Protein Ligase
- (2010) Saravanakumar Iyappan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification and Characterization of the First Small Molecule Inhibitor of MDMX
- (2010) Damon Reed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Systematic Mutational Analysis of Peptide Inhibition of the p53–MDM2/MDMX Interactions
- (2010) Chong Li et al. JOURNAL OF MOLECULAR BIOLOGY
- Widespread Overexpression of Epitope-Tagged Mdm4 Does Not Accelerate Tumor Formation In Vivo
- (2010) S. De Clercq et al. MOLECULAR AND CELLULAR BIOLOGY
- The Novel Tryptamine Derivative JNJ-26854165 Induces Wild-Type p53- and E2F1-Mediated Apoptosis in Acute Myeloid and Lymphoid Leukemias
- (2010) K. Kojima et al. MOLECULAR CANCER THERAPEUTICS
- A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis
- (2010) H. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Apamin as a Template for Structure-Based Rational Design of Potent Peptide Activators of p53
- (2009) Chong Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- RING Domain E3 Ubiquitin Ligases
- (2009) Raymond J. Deshaies et al. Annual Review of Biochemistry
- N-Acylpolyamine inhibitors of HDM2 and HDMX binding to p53
- (2009) Ryo Hayashi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- β-Peptides with improved affinity for hDM2 and hDMX
- (2009) Elizabeth A. Harker et al. BIOORGANIC & MEDICINAL CHEMISTRY
- MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway
- (2009) Francesca Mancini et al. EMBO JOURNAL
- MDM2/MDMX inhibitor peptide: WO2008106507
- (2009) Antonio Macchiarulo et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Susceptibility of p53 Unstructured N Terminus to 20 S Proteasomal Degradation Programs the Stress Response
- (2009) Peter Tsvetkov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes
- (2009) Joerg Kallen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In Silico Improvement of β3-Peptide Inhibitors of p53•hDM2 and p53•hDMX
- (2009) Julien Michel et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?
- (2009) Mark Wade et al. MOLECULAR CANCER RESEARCH
- Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
- (2009) M. Pazgier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the conformational transitions of MDM2 and MDMX: Insights into key residues affecting p53 recognition
- (2009) Andrea Carotti et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Small-molecule inhibitors of MDM2 as new anticancer therapeutics
- (2009) Michael P. Dickens et al. SEMINARS IN CANCER BIOLOGY
- Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
- (2008) Sanjeev Shangary et al. Annual Review of Pharmacology and Toxicology
- Expression of p14ARF , MDM2 , and MDM4 in human retinoblastoma
- (2008) Ying Guo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans
- (2008) K Linke et al. CELL DEATH AND DIFFERENTIATION
- High-Resolution Array-Based Comparative Genomic Hybridization of Bladder Cancers Identifies Mouse Double Minute 4 (MDM4) as an Amplification Target Exclusive of MDM2 and TP53
- (2008) A. Veerakumarasivam et al. CLINICAL CANCER RESEARCH
- Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer
- (2008) Sharmila Patel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeting the Conformational Transitions of MDM2 and MDMX: Insights into Dissimilarities and Similarities of p53 Recognition
- (2008) Antonio Macchiarulo et al. Journal of Chemical Information and Modeling
- Structure of Human MDM4 N-Terminal Domain Bound to a Single-Domain Antibody
- (2008) Grace W. Yu et al. JOURNAL OF MOLECULAR BIOLOGY
- Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties
- (2008) Andrea Prodosmo et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Mdm2 and Mdm4 Loss Regulates Distinct p53 Activities
- (2008) J. A. Barboza et al. MOLECULAR CANCER RESEARCH
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
- (2008) S. Shangary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation